Vivanza Biosciences Confirms Non-Applicability of SEBI Regulation 32 Statement of Deviation
Vivanza Biosciences Ltd 路 Others (Uncategorized) 路 08 Oct 2026, 5:00 pm
Vivanza Biosciences Confirms Non-Applicability of SEBI Regulation 32 Statement of Deviation Vivanza Biosciences Limited informed BSE on 8th Oct'26 regarding the non-applicability of the Statement of Deviation or Variation under Regulation 32 of SEBI (LODR) Regulations, 2015. The company confirmed that it has not raised any further capital through public issues, rights issues, preferential issues, or Qualified Institutions Placements (QIP), rendering the submission of a deviation or variation statement non-applicable.
Original exchange filing (PDF)
More announcements from Vivanza Biosciences Ltd
- Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform .... 路 07 Nov 2026
- Non-applicability of Reg 23 (9) of SEBI (LODR) Regulation, 2015 for the Quarter on 30th September, 2026. 路 29 Oct 2026
- Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve unaudited standalone and .... 路 03 Nov 2026
- Voting Result for the 44th Annual General Meeting of the Company 路 12 Sept 2026
- Revised Outcome of the 44th Annual General Meeting of the Vivanza Biosciences Limited 路 12 Sept 2026
- Outcome of the 44th Annual General Meeting of the Members of the Vivanza Biosciences Limited. 路 11 Sept 2026
- Please find enclosed newspaper advertisement w.r.t Notice of 44th AGM of the Company and e-voting information. 路 20 Aug 2026
- Annual Report for the Financial Year 2025-2026 of the Company. 路 19 Aug 2026
